Controversies in Ocular Toxoplasmosis

被引：38

作者：

Wakefield, Denis ^{[2
,3
]}

Cunningham, Emmett T., Jr. ^{[4
,5
]}

Pavesio, Carlos ^{[6
]}

Garweg, Justus G. ^{[7
,8
]}

Zierhut, Manfred ^{[1
]}

机构：

[1] Univ Tubingen, Ctr Ophthalmol, D-72076 Tubingen, Germany

[2] Univ New Sourth Wales, St Vincents Eye Clin, Sydney, NSW, Australia

[3] Univ New Sourth Wales, Sch Med Sci, Sydney, NSW, Australia

[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[5] Calif Pacific Med Ctr, San Francisco, CA USA

[6] Moorfields Eye Hosp, London, England

[7] Univ Bern, Bern, Switzerland

[8] Swiss Eye Inst, Bern, Switzerland

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2011年 / 19卷 / 01期

关键词：

toxoplasmosis; uveitis; epidemiology; pathogenesis; treatment; retionochoroiditis; inflammation antibiotics;

D O I：

10.3109/09273948.2011.547157

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Toxoplasmosis, a major cause of infectious uveitis, was elected by the editors of Ocular Immunology and Inflammation as the disease of the year for 2011. The aim of the present review was to report on the results of a survey of leading uveitis experts, in which the authors asked participants to address some of the most important issues related to diagnosis, pathophysiology, and treatment of ocular toxoplasmosis. The survey revealed generally good consensus regarding clinical signs of typical and atypical toxoplasmic retinochoroiditis. In contrast, views regarding diagnostic approach, possible epidemiological influences, transmission of disease, and trigger factors seemed less clearly defined. Responses revealed a large number of drug regimens in use for both congenital and acquired disease. Finally, recurrence prophylaxis was not regularly recommended by the majority of experts.

引用

页码：2 / 9

页数：8